Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:23 PM UTC
| NCT Number | NCT06293898 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE1 |
| Target Enrollment | 280 participants |
| Active Locations | 26 sites in the US |
| Sponsor | SystImmune Inc. |
| Last Updated on CT.gov | October 8, 2026 (4 days ago) |
As of October 12, 2026: Clinical trial NCT06293898 is currently recruiting participants. This phase1 study for endometrial cancer is actively seeking new participants at 26 locations across the United States. The study is sponsored by SystImmune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06293898 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06293898 was last updated 4 days ago (October 8, 2026). HelloStudys verifies this status automatically.